Specifically, these techniques are beneficial for the diagnosis of NDM with unknown genetic origin, which is required for responding to sulphonylurea (Glyburide), insulin therapy for PNDM neonates, and for future therapy cases (Barbetti et al., 2018). Here, INS is linked to neonatal diabetes mellitus.